Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells
- PMID: 19913446
- DOI: 10.1016/j.immuni.2009.08.027
Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells
Abstract
The expression of the chemokine receptor XCR1 and the function of its ligand XCL1 (otherwise referred to as ATAC, lymphotactin, or SCM-1) remained elusive to date. In the present report we demonstrated that XCR1 is exclusively expressed on murine CD8(+) dendritic cells (DCs) and showed that XCL1 is a potent and highly specific chemoattractant for this DC subset. CD8(+) T cells abundantly secreted XCL1 8-36 hr after antigen recognition on CD8(+) DCs in vivo, in a period in which stable T cell-DC interactions are known to occur. Functionally, XCL1 increased the pool of antigen-specific CD8(+) T cells and their capacity to secrete IFN-gamma. Absence of XCL1 impaired the development of cytotoxicity to antigens cross-presented by CD8(+) DCs. The XCL1-XCR1 axis thus emerges as an integral component in the development of efficient cytotoxic immunity in vivo.
Similar articles
-
Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice.Biochem Biophys Res Commun. 2010 Jul 9;397(4):756-61. doi: 10.1016/j.bbrc.2010.06.029. Epub 2010 Jun 10. Biochem Biophys Res Commun. 2010. PMID: 20541533
-
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells.Front Immunol. 2018 Nov 27;9:2775. doi: 10.3389/fimmu.2018.02775. eCollection 2018. Front Immunol. 2018. PMID: 30542351 Free PMC article.
-
XCL1 and XCR1 in the immune system.Microbes Infect. 2012 Mar;14(3):262-7. doi: 10.1016/j.micinf.2011.10.003. Epub 2011 Oct 31. Microbes Infect. 2012. PMID: 22100876 Review.
-
Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.J Immunol. 2015 Feb 1;194(3):1069-79. doi: 10.4049/jimmunol.1401903. Epub 2014 Dec 17. J Immunol. 2015. PMID: 25520399
-
Killer dendritic cells and their potential role in immunotherapy.Horm Metab Res. 2008 Feb;40(2):75-81. doi: 10.1055/s-2007-1022554. Horm Metab Res. 2008. PMID: 18283624 Review.
Cited by
-
Chemokines and the immune response to cancer.Immunity. 2021 May 11;54(5):859-874. doi: 10.1016/j.immuni.2021.01.012. Epub 2021 Apr 10. Immunity. 2021. PMID: 33838745 Free PMC article. Review.
-
Recent Progress in Dendritic Cell-Based Cancer Immunotherapy.Cancers (Basel). 2021 May 20;13(10):2495. doi: 10.3390/cancers13102495. Cancers (Basel). 2021. PMID: 34065346 Free PMC article. Review.
-
Human dendritic cell subsets and function in health and disease.Cell Mol Life Sci. 2015 Nov;72(22):4309-25. doi: 10.1007/s00018-015-2005-0. Epub 2015 Aug 5. Cell Mol Life Sci. 2015. PMID: 26243730 Free PMC article. Review.
-
cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8+ T Cell Memory and Protective Immunity.J Immunol. 2020 Feb 1;204(3):510-517. doi: 10.4049/jimmunol.1901357. Epub 2019 Dec 23. J Immunol. 2020. PMID: 31871021 Free PMC article.
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model.Sci Rep. 2022 Dec 13;12(1):21570. doi: 10.1038/s41598-022-25065-w. Sci Rep. 2022. PMID: 36513720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials